ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,064.20
0.91%
Dow Jones
38,225.66
0.85%
US Dollar vs MXN
16.9727
0.00%
Brent Oil
83.89
0.31%
Bitcoin
59,174.02
0.09%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. USOTC
  6. Zenosense Inc NV (CE) (ZENO)

  7. Zenosense Inc NV (CE) (ZENO) Noticias

ZENO

Zenosense Inc NV (CE) (ZENO)

Zenosense Inc NV (CE)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:USOTC:ZENO
FechaHoraFuenteTítuloSímboloCompañía
20/04/202211:39Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ZENOZenosense Inc NV (CE)
16/03/202209:50Edgar (US Regulatory)Annual Report (10-k)USOTC:ZENOZenosense Inc NV (CE)
16/03/202205:05Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ZENOZenosense Inc NV (CE)
01/03/202210:41Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:ZENOZenosense Inc NV (CE)
01/04/201914:00Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:ZENOZenosense Inc NV (CE)
02/10/201806:42InvestorsHub NewsWireZenosense, Inc.: MIDS Medical Expands Technical TeamUSOTC:ZENOZenosense Inc NV (CE)
05/09/201807:00InvestorsHub NewsWireZenosense, Inc.: MIDS Medical JV to Receive Funding of Up to $1.2 MillionUSOTC:ZENOZenosense Inc NV (CE)
14/08/201810:05Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ZENOZenosense Inc NV (CE)
26/06/201807:45InvestorWireDiagnostics Play Critical Role in Medical SectorUSOTC:ZENOZenosense Inc NV (CE)
19/06/201806:52InvestorsHub NewsWireZenosense, Inc.: Breakthrough Quantitative MIDS Testing ResultsUSOTC:ZENOZenosense Inc NV (CE)
16/11/201706:38InvestorsHub NewsWireZenosense, Inc.: MIDS Hybrid Strip - Successful Initial Test ResultsUSOTC:ZENOZenosense Inc NV (CE)
05/07/201706:54InvestorsHub NewsWireZenosense, Inc. - MIDS Hybrid Strip Detection Testing to CommenceUSOTC:ZENOZenosense Inc NV (CE)
15/06/201706:47InvestorsHub NewsWireZenosense, Inc.: Issuance of U.S. MIDS PatentUSOTC:ZENOZenosense Inc NV (CE)
19/05/201714:10Edgar (US Regulatory)Amended Quarterly Report (10-q/a)USOTC:ZENOZenosense Inc NV (CE)
20/04/201708:00InvestorsHub NewsWireWhat Cannabis Stocks Investors Should Know and Coverage of a Mobile Tech Sub Penny StockUSOTC:ZENOZenosense Inc NV (CE)
28/03/201708:15InvestorsHub NewsWireZenosense, Inc.: MIDS Medical Engages Future Diagnostics for Assay Consulting ServicesUSOTC:ZENOZenosense Inc NV (CE)
10/03/201706:36InvestorsHub NewsWireZenosense, Inc.: MIDS Quantitative Testing ResultsUSOTC:ZENOZenosense Inc NV (CE)
06/02/201714:10Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:ZENOZenosense Inc NV (CE)
23/01/201707:47InvestorsHub NewsWireZenosense, Inc.: New Patent Application for Additional MIDS Detection MethodUSOTC:ZENOZenosense Inc NV (CE)
17/11/201609:00InvestorsHub NewsWireZenosense, Inc. MIDS Proof of Market ReportUSOTC:ZENOZenosense Inc NV (CE)
29/06/201614:44Edgar (US Regulatory)Information Statement - All Other (definitive) (def 14c)USOTC:ZENOZenosense Inc NV (CE)
17/06/201615:45Edgar (US Regulatory)Proxy Statement - Other Information (preliminary) (pre 14c)USOTC:ZENOZenosense Inc NV (CE)
16/06/201616:11Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:ZENOZenosense Inc NV (CE)
16/06/201613:51Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:ZENOZenosense Inc NV (CE)
17/12/201407:50InvestorsHub NewsWireZenosense, Inc. - Hospital Collaboration - 400 Person Lung Cancer Detection TrialUSOTC:ZENOZenosense Inc NV (CE)
27/10/201408:00eTeligisZenosense, Inc.; MRSA/SA Prototype Achieves over 95% Sensibility in Cultured HeadspaceUSOTC:ZENOZenosense Inc NV (CE)
27/05/201407:30MarketwiredZenosense, Inc. Highlights Recent Media Coverage of MRSAUSOTC:ZENOZenosense Inc NV (CE)
21/05/201407:30MarketwiredZenosense, Inc. Provides Development UpdateUSOTC:ZENOZenosense Inc NV (CE)
08/05/201407:30MarketwiredZenosense, Inc. Extends License to Include Cancer ApplicationsUSOTC:ZENOZenosense Inc NV (CE)
10/04/201408:27MarketwiredZenosense, Inc. Enters Into $475,000 Securities Purchase AgreementUSOTC:ZENOZenosense Inc NV (CE)
 Showing the most relevant articles for your search:USOTC:ZENO

Su Consulta Reciente

NASDAQ
TSLA
Tesla
AMEX
SPY
SPDR S&P 500
NYSE
CVX
Chevron
USOTC
BNPQY
BNP Paribas (QX)
NYSE
AXP
American Express
AMEX
XLV
Health Care Select Sector
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
AAPL
Apple
FX
EURMXN
Euro vs MXN
NYSE
BAC
Bank of America
NYSE
DIS
Walt Disney
PM
XAUUSD
Gold vs US Dollar
AMEX
XLF
Financial Select Sector
USOTC
RHHBY
Roche (QX)
USOTC
ADDYY
Adidas (QX)
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados